Evaluating and Standardizing Therapeutic Agents, 1890-1950

Chapter 1 Introduction: Evaluating and Standardizing Therapeutic Agents, 1890–1950

Chapter 2 Paul Ehrlich’s Standardization of Serum: Wertbestimmung and Its Meaning for Twentieth-Century Biomedicine

Chapter 3 Evaluation as a Practical Technique of Administration: The Regulation and Standardization of Diphtheria Serum

Chapter 4 From Diphtheria to Tetanus: The Development of Evaluation Methods for Sera in Imperial Germany

Chapter 5 The Construction of a Culture of Standardization at the Institut Pasteur (1885–1900)

Chapter 6 Quality Control and the Politics of Serum Production in France

Chapter 7 ‘The Geneva serum is excellent!’ Autonomy and Isolation in the Swiss Cantons During the Early Years of Diphtheria Serum: The Case of Geneva

Chapter 8 The State, the Serum Institutes and the League of Nations

Chapter 9 Evaluating and Standardizing Therapeutic Agents, 1890–1950

Chapter 11 The Visible Industrialist: Standards and the Manufacture of Sex Hormones

Chapter 12 ‘We need for digitalis preparations what the state has established for serumtherapy …’ From Collecting Plants to International Standardization: The Case of Strophanthin, 1900–38

Chapter 13 Changing Regulations and Risk Assessments: National Responses to the Introduction of Inactivated Polio Vaccine in the UK and West Germany

Chapter 14 Standardization Before Biomedicine: On Early Forms of Regulatory Objectivity